Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDMO
Biotech
Biopharma Q2 VC hit highest level since ’22, while M&A slowed
Venture capital in biopharma rose to $9.2 billion across 215 deals in the second quarter of this year—the highest funding level since 2022.
Gabrielle Masson
Aug 23, 2024 4:00am
Charles River Labs partners with Wheeler Bio for CMC platform
Feb 26, 2024 3:15pm
QHP buys cell and gene therapy specialist Applied StemCell
Oct 9, 2023 10:20am
GlucoModicum taps Phillips-Medisize to develop needle-free CGM
Oct 4, 2023 10:55am
NightHawk dives into CDMO, leaving R&D staffers in the lurch
Sep 20, 2023 10:33am
Symeres acquires Exemplify BioPharma in 2nd US buy this year
Oct 26, 2022 5:00am